Government appoints Controller for Medical Products Regulation (with photo)

The Government announced today (October 12) that, following a global open recruitment exercise, Mr Li Zili will take up the appointment as the Controller for Medical Products Regulation under the Department of Health (DH) for a three-year term with effect from October 20, 2026. The Centre for Medical Products Regulation (CMPR) will be set up in 2026 to promote proactive "primary evaluation", accelerate the clinical application of drugs and medical devices (medical products) and enable patients to access state-of-the-art medical products that meet the requirements of quality and safety. "As set out in the First Five-Year Plan for Economic and Social Development of the Hong Kong Special Administrative Region (2026-2030), Hong Kong will comprehensively intensify the regulatory reform of medical products, enhance our regulatory regime to align with international standards, develop the capacity for independent evaluation and approval of medical products, and participate actively in international regulation of medical products to pursue recognition from international authorities. The Chief Executive's 2026 Policy Address also announced that, to dovetail with our country's strategic devel

Résiliable à tout moment · 99 $ CA/mois